NASDAQ:RBPAA Royal Bancshares of Pennsylvania (RBPAA) Stock Price, News & Analysis → The #1 Opportunity of the decade? (From Behind the Markets) (Ad) Free RBPAA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$4.48▼$4.5550-Day Range N/A52-Week Range$3.13▼$4.87Volume22,261 shsAverage Volume60,237 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Royal Bancshares of Pennsylvania alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Royal Bancshares of PennsylvaniaRoyal Bancshares of Pennsylvania, Inc. is a bank holding company. The Company offers a range of financial and banking products and services. The principal activities of the Company are supervising Royal Bank America (Royal Bank), which engages in general banking business. It operates through two segments: Community Banking and Tax Liens. Its community banking segment consists of commercial and retail banking and equipment leasing. The community banking business segment includes Royal Bank and Royal Bank Leasing, and offers a range of products and services. Its tax liens segment includes ownership interest in Crusader Servicing Corporation and Royal Tax Lien Services, LLC. Royal Bank conducts business operations as a commercial bank offering consumer and business deposit products and services, and commercial and consumer loans, including home equity and small business administration loans. It also offers a range of services, such as cash management products and mobile deposits.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> RBPAA Stock News HeadlinesApril 17, 2024 | msn.comRoyal Bank of Scotland to close a fifth of branchesMarch 4, 2024 | marketwatch.comHow to Start an LLC in Pennsylvania (2024 Guide)April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.February 9, 2024 | health.usnews.comTamara JohnsonJanuary 22, 2024 | news.yahoo.comTrump to address NRA members in PennsylvaniaJanuary 17, 2024 | msn.comChanges made to Pennsylvania tax credit, rent rebate program; filing period now openDecember 7, 2023 | bbc.comRoyal wedding 2018: Order of serviceNovember 12, 2023 | usatoday.comUniversity of Pennsylvania students chanted 'We charge you with genocide' at rally | Fact checkApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.November 8, 2023 | msn.comFirst Guaranty Bancshares cut to Underweight at Piper on profit profileOctober 26, 2023 | foxnews.comPennsylvania K-9 who helped catch convicted murderer retires after eight years of service: 'He loved to work'October 25, 2023 | health.usnews.comJohn R. YoungOctober 13, 2023 | health.usnews.comMichelle M. ForcinaOctober 13, 2023 | health.usnews.comLindsay J. AchsOctober 11, 2023 | health.usnews.comSierra D. CuppettSeptember 17, 2023 | foxnews.comPennsylvania authorities alerted to possible sighting of convicted killer who escaped prisonSeptember 15, 2023 | usatoday.com'Extremely dangerous' man escapes Pa. prison after getting life for murdering ex-girlfriendJuly 30, 2023 | health.usnews.comBest Hospitals in PennsylvaniaJuly 25, 2023 | markets.businessinsider.comRBC Capital Sticks to Its Buy Rating for Huntington Bancshares (HBAN)July 24, 2023 | msn.comRBC Capital Reiterates Huntington Bancshares (HBAN) Outperform RecommendationJune 16, 2023 | finance.yahoo.comHWBK - Hawthorn Bancshares, Inc.June 10, 2023 | fortune.comUniversity of Pennsylvania (Wharton)April 28, 2023 | msn.comRBC Capital Maintains Prosperity Bancshares (PB) Sector Perform RecommendationApril 23, 2023 | msn.comRBC Capital Reiterates Home Bancshares (HOMB) Sector Perform RecommendationMarch 17, 2023 | travel.usnews.comRoyal Palace of Madrid (Palacio Real)March 13, 2023 | thestreet.comBank M&A Complicated by FailuresFebruary 24, 2023 | usnews.comUniversity of PennsylvaniaSee More Headlines Receive RBPAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Royal Bancshares of Pennsylvania and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:RBPAA CUSIPN/A CIK922487 Webwww.royalbankamerica.com Phone+1-610-6684700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesRobert R. Tabas (Age 60)Chairman of the Board Frank Kevin Tylus (Age 61)President, Chief Executive Officer, Director Michael S. Thompson (Age 44)Chief Financial Officer Mark W. BiedermannExecutive Vice President, Chief Lending OfficerLars B. Eller (Age 48)Executive Vice President, Chief Retail Officer Linda Tabas Stempel (Age 64)Director Murray Stempel III (Age 61)Director Howard J. Wurzak (Age 61)Director Edward F. Bradley CPA (Age 72)Independent Director Wayne R. Huey Jr. (Age 71)Independent Director More Executives This page (NASDAQ:RBPAA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royal Bancshares of Pennsylvania Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.